1. Corporate Officers - O
2. Oltmans Curtis Gale

Insider Trading History of Oltmans Curtis Gale

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Oltmans Curtis Gale since 2018. This trader's CIK number is 1714982. At the time of last reporting, Oltmans Curtis Gale was the Chief Legal Officer of Fulcrum Therapeutics, Inc.. (stock ticker symbol FULC). Also see all insider trading activities at Fulcrum Therapeutics, Inc..

Note that in the past Oltmans Curtis Gale also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Fulcrum Therapeutics, Inc. (FULC) by Oltmans Curtis Gale

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	FULC	0	$0	3,452	$44,599	0	$0

Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Oltmans Curtis Gale

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	ARRY	0	$0	75,000	$1,431,183	86,100	$769,732
2018	ARRY	0	$0	0	$0	7,000	$0

Insider trading activities at 2 companies by Oltmans Curtis Gale:

1. Fulcrum Therapeutics, Inc. (FULC)

2. Array Biopharma Inc (ARRY)

Table 1. Insider trading of Fulcrum Therapeutics, Inc. (FULC) by Oltmans Curtis Gale

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-12-15	FULC	Sale	3,452	12.92	44,599

Table 2. Insider trading of Array Biopharma Inc (ARRY) by Oltmans Curtis Gale

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-02-05	ARRY	Option Ex	40,000	8.94	357,600
2019-02-05	ARRY	Sale	40,000	20.00	800,000
2019-01-29	ARRY	Option Ex	11,100	8.94	99,234
2019-01-25	ARRY	Option Ex	14,029	8.94	125,419
2019-01-25	ARRY	Sale	14,029	18.00	252,522
2019-01-18	ARRY	Sale	1,251	18.00	22,518
2019-01-18	ARRY	Option Ex	1,251	8.94	11,183
2019-01-15	ARRY	Option Ex	19,720	8.94	176,296
2019-01-15	ARRY	Sale	19,720	18.06	356,143
2018-12-16	ARRY	Option Ex	7,000	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oltmans Curtis Gale (Chief Legal Officer of Fulcrum Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month